As drugs like Ozempic and Mounjaro reshape appetites worldwide, restaurants, supermarkets and fast food chains are pivoting to smaller portions, protein-heavy menus and flexible dining formats. With cheaper GLP1 generics set to flood India, how will a culture built on abundance cope?